Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
Research reports from Kagawa University, Department of Pharmacy provide new insights into adverse drug reactions
June 26th, 2007
Investigators publish new data in the report "Preventive effects of low-dose dexamethasone for delayed adverse events induced by carboplatin-based combination chemotherapy." According to recent research published in the Yakugaku Zasshi Journal of the Pharmaceutical Society of Japan, "We performed a retrospective study to examine the protective effect of low-dose dexamethasone (DEX) on delayed adverse events induced by carboplatin (CBDCA)-based combination chemotherapy in patients with thoracic tumors. Low-dose DEX (4-8 mg/day) was administered on day 1 and after, in addition to a serotonin 5-HT3 receptor antagonist." "The acute adverse events (day 1) were well...
Source: Drug Law Weekly (2007-06-26)
|
